NCT03301285View on ClinicalTrials.gov

Efficacy of Zoledronic Acid in Osteoporosis of Children With Multiple Disabilities

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Multiple DisabilityOsteoporosis
Interventions
DRUG

Zoledronic Acid

Treatment of osteoporosis

Trial Locations (1)

Unknown

Children's Hospital - CHRU de Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT03301285 - Efficacy of Zoledronic Acid in Osteoporosis of Children With Multiple Disabilities | Biotech Hunter | Biotech Hunter